Novartis India Sep '11 sales at Rs 215.07 crore

Published on Wed, Nov 02, 2011 at 15:58 |  Source : Moneycontrol.com

2455 Investors following Novartis India. Share this News with them.
0
0
Share on Tumblr
Novartis India Sep '11 sales at Rs 215.07 crore

ALSO READ

Novartis India has reported a sales turnover of Rs 215.07 crore and a net profit of Rs 43.18 crore for the quarter ended Sep '11.
For the quarter ended Sep 2010 the sales turnover was Rs 196.04 crore and net profit was Rs 40.56 crore.
Quarterly Results of Novartis India-------- in Rs. Cr. --------
Sep '10Jun '11Sep '11
Sales Turnover196.04197.78215.07
Other Income15.5616.7418.30
Total Income211.60214.52233.37
Total Expenses151.43158.08167.47
Operating Profit44.6139.7047.60
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses------
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit60.1756.4465.90
Interest0.060.080.18
PBDT60.1156.3665.72
Depreciation0.530.430.72
Depreciation On Revaluation Of Assets------
PBT59.5855.9365.00
Tax19.0218.3621.82
Net Profit40.5637.5743.18
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share12.6911.7613.51
Book Value------
Equity15.9815.9815.98
Reserves------
Face Value5.005.005.00
Source : Dion Global Solutions Limited

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!